Reply to "Immunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines"
- PMID: 26604265
- PMCID: PMC4658587
- DOI: 10.1128/CVI.00504-15
Reply to "Immunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines"
Comment on
-
Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression.Clin Vaccine Immunol. 2015 Jul;22(7):798-805. doi: 10.1128/CVI.00034-15. Epub 2015 May 13. Clin Vaccine Immunol. 2015. PMID: 25972402 Free PMC article.
-
Immunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines.Clin Vaccine Immunol. 2015 Dec;22(12):1294-5. doi: 10.1128/CVI.00497-15. Clin Vaccine Immunol. 2015. PMID: 26604264 Free PMC article. No abstract available.
References
-
- Patel M, Carritt K, Lane J, Jayappa H, Stahl M, Bourgeois M. 2015. Comparative efficacy of feline leukemia virus (FeLV) inactivated whole-virus vaccine and canarypox virus-vectored vaccine during virulent FeLV challenge and immunosuppression. Clin Vaccine Immunol 22:798–805. doi: 10.1128/CVI.00034-15. - DOI - PMC - PubMed
-
- Grosenbaugh DA, Leard T, Pardo MC, Motes-Kreimeyer L, Royston M. 2004. Comparison of the safety and efficacy of a recombinant feline leukemia virus (FeLV) vaccine delivered transdermally and an inactivated FeLV vaccine delivered subcutaneously. Vet Ther 5:258–262. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
